Accelerated atherosclerosis in patients with systemic lupus erythematosus: a review of the causes and possible prevention.
Publication in refereed journal


全文

其它資訊
摘要Systemic lupus erythematosus is an autoimmune disorder affecting multiple organ systems. Patients with systemic lupus erythematosus exhibit a bimodal pattern of mortality, with those who have had the disease for 5 to 10 years being at increased risk of cardiovascular disease, particularly myocardial infarction. Elevated levels of conventional cardiovascular risk factors promote vascular damage resulting in impairment of normal endothelial function. In addition, autoantibodies directed against oxidised lipoproteins, along with chronic secretion of inflammatory cytokines and suppression of fibrinolytic parameters, are thought to increase atherogenesis. Treatment with corticosteroids may also contribute to the accelerated atherosclerosis observed in these patients. This review discusses the accentuated relationship between conventional cardiovascular risk factors, systemic lupus erythematosus-induced inflammatory changes and the early stages of atherogenesis and how careful monitoring of risk factors and use of appropriate therapies may reduce the progression of atheroma development in patients with systemic lupus erythematosus.
著者Thomas G.N., Tam L.S., Tomlinson B., Li E.K.
期刊名稱Hong Kong Medical Journal
出版年份2002
月份2
日期1
卷號8
期次1
出版社Hong Kong Academy of Medicine Press
出版地Hong Kong
頁次26 - 32
國際標準期刊號1024-2708
電子國際標準期刊號2226-8707
語言英式英語

上次更新時間 2021-18-10 於 23:33